Armgo Pharma
Biotechnology, 923 Saw Mill River Road, Ardsley, New York, 10502, United States, 1-10 Employees
Phone Number: +12*********
Who is ARMGO PHARMA
ARMGO is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human disea...
Read More
- Headquarters: 923 Saw Mill River Road, Ardsley, New York, 10502, United States
- Date Founded: 2004
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Gene Marcantonio
Industry: Biotechnology
SIC Code: 2834 | NAICS Code: 325412 | Show More
Does something look wrong? Fix it. | View contact records from ARMGO PHARMA
ARMGO Pharma Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ARMGO Pharma
Answer: ARMGO Pharma's headquarters are located at 923 Saw Mill River Road, Ardsley, New York, 10502, United States
Answer: ARMGO Pharma's phone number is +12*********
Answer: ARMGO Pharma's official website is https://armgo.com
Answer: ARMGO Pharma's revenue is $1 Million to $5 Million
Answer: ARMGO Pharma's SIC: 2834
Answer: ARMGO Pharma's NAICS: 325412
Answer: ARMGO Pharma has 1-10 employees
Answer: ARMGO Pharma is in Biotechnology
Answer: ARMGO Pharma contact info: Phone number: +12********* Website: https://armgo.com
Answer: ARMGO is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human diseases. Our primary focus is on two orphan diseases: the life-threatening cardiac disease Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and the severe muscle disease RYR1-Related Myopathy (RYR1-RM). These two conditions occur due to genetic mutations in the RYR gene: RYR1 in RYR1-RM, and RYR2 in most CPVT cases. ARMGO’s molecules, termed Rycals® are designed to repair leaky RyR channels. Since the cause of the symptoms is abnormal calcium leak due to these mutations, Rycals hold the promise of disease-modifying therapy for these two orphan genetic diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month